ARCHIVES

House Committee Alleges Irregularities In Tamoxifen Trial Informed Consent Forms

This article is from The Cancer Letter archive.

Vol. 18 No. 42 | October 30, 1992

Download PDF Visit The Full Archive

Related Articles

Excitement building toward 2015 goal, NCI director says in FY07 bypass budget request. NCI seeks $5.8 billion.

December 2, 2005

FDA Approves Xeloda For Breast Cancer Treatment.

September 28, 2001

PV-10 Produces 51 Percent Response Rate in Phase II Trial

October 26, 2012

Weinstein Receives Award; LRFA Honors Vincent Devita.

June 23, 2000

President Obama Visits NIH To Announce 12,000 Recovery Act Grants Worth $5 Billion

October 2, 2009

Elevated Baseline Glucose Levels Associated With Higher Cancer Risk

November 25, 2011